baber/WOPTO huggingface dataset:
Patent AU-2019296402-A1 (AU)
Title: Improved geographic indexing
Inventor: CHLEBCOVA MARTINA
IPC: G06T11/20
Filed: 2019-06-25
Abstract: The current invention relates to a computer-implemented method for creating an overlay map, preferably a heat map, comprising: receiving at a server a user request for creation of the overlay map; loading vector data at the server comprising location data, the location data comprising at least one attribute; converting the vector data to image data composed of pixels according to an index scale; applying the converted image data to a color ramp; and creating the overlay map based on the converted image data and the color ramp; wherein said vector data is organized according to a plurality of layers, the location data comprising at least one attribute for each layer.
Patent AU-2019299631-A1 (AU)
Title: Double row barrel ice maker with overhead extraction
Inventor: JUNGE BRENT ALDEN
IPC: F25C5/00
Filed: 2019-07-02
Abstract: An ice maker (160) includes a mold body (170) with two rows of mold cavities (200) defined in the mold body (170). The ice maker (160) also includes an ejector assembly (180) having a plurality of ejector pads (210) corresponding to the mold cavities (200). The ejector pads (210) are movable between a low position proximate to the floor (202) of a corresponding mold cavity (200) and a high position proximate the opening of each corresponding mold cavity (200). The ejector pads (210) are operable to eject ice from the mold cavities (200) when the ejector assembly (180) moves from the low position to the high position. A related refrigerator appliance (100) is also provided.
Patent AU-2019348407-A1 (AU)
Title: Breast pump
Inventor: MASUCCI ANDREA
IPC: A61M1/06
Filed: 2019-09-23
Abstract: An electrically operated breast pump for pumping human breast milk comprises an electrical pump unit (15) and an electronic control unit (14) for controlling the pump unit (15). The pump unit (15) can be activated by the control unit (14) in a time-delayed manner. The breast pump according to the invention allows a stress-free start of the process of pumping breast milk in a simple manner.
Patent AU-2019355110-A1 (AU)
Title: Systems and methods for cryptographic authentication of contactless cards
Inventor: OSBORN KEVIN
IPC: G07F7/12
Filed: 2019-10-02
Abstract: Example embodiments of systems and methods for data transmission between transmitting and receiving devices are provided. In an embodiment, each of the transmitting and receiving devices can contain a master key. The transmitting device can generate a diversified key using the master key, protect a counter value and encrypt data prior to transmitting to the receiving device. The receiving device can generate the diversified key based on the master key and can decrypt the data and validate the protected counter value using the diversified key.
Patent AU-2019393256-A1 (AU)
Title: CRF1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia
Inventor: FARBER ROBERT H
IPC: A61K9/00
Filed: 2019-12-06
Abstract: Provided are methods related to treating congenital adrenal hyperplasia in a subject in need thereof comprising administering 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[( 1 S)-2-cyclopropyl- 1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-prop-2-ynyl-l,3-thiazol-2-amine (Formula 1), or a pharmaceutically acceptable salt thereof. Further provided are pharmaceutical formulations and solid forms of 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(lS)-2-cyclopropyl-l-(3-fluoro-4-methylphenyl)ethyl]-5-mcthyl-N -prop-2 -ynyl-l,3-thiazol-2-amine, or a pharmaceutically acceptable salt thereof, and their use in the treatment of congenital adrenal hyperplasia (CAH).
Patent AU-2019404934-A1 (AU)
Title: Macrocyclic compounds and their use in the treatment of disease
Inventor: AZIMIOARA MIHAI
IPC: A61P11/00
Filed: 2019-12-18
Abstract: The invention relates to heterocyclic compounds of the formula (I), in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.
Patent AU-2019432491-A1 (AU)
Title: Heat management device for electric vehicle power battery suitable for use in extremely cold regions
Inventor: YUAN WEI
IPC: H01M10/635
Filed: 2019-10-23
Abstract: Disclosed by the present invention a heat management device for an electric vehicle power battery suitable for use in extremely cold regions, the heat management device comprising a thermal insulation box body, a cooling device, a battery temperature detection element, and a control processor module; when in use, a battery is placed at a battery holding part inside of the thermal insulation box body, such that a heat absorption part of the cooling device and the battery temperature detection element are attached to the battery; during operation, when the temperature of the battery is higher than a preset value, the battery temperature detection element transmits a signal to the control processor module, the control processor module then controls the cooling device to start a cooling operation, the heat absorption part of the cooling device absorbs heat and transfers waste heat to a heat dissipation part, which then dissipates the waste heat to the outside of the thermal insulation box body; when the temperature of the battery is lower than the preset value, the battery temperature detection element transmits a signal to the control processor module, which then controls the cooling device to stop the cooling operation, and then heat produced by the continuous heating of the battery is accumulated at the thermal insulation box body.
Patent AU-2019448236-A1 (AU)
Title: Animal model of idiopathic pulmonary fibrosis, its construction method and use
Inventor: TANG NAN
IPC: A01K67/027
Filed: 2019-05-30
Abstract: Provided are a method for constructing an animal model of pulmonary fibrosis, in particular, idiopathic pulmonary fibrosis (IPF), the constructed animal model using the said method, and a method for screening the candidate drugs for treating pulmonary fibrosis, in particular, idiopathic pulmonary fibrosis (IPF).
Patent AU-2019460208-A1 (AU)
Title: Method for culturing primary cells of lung cancer solid tumor and primary tumor cells of lung cancer pleural effusion, and supporting reagent
Inventor: Yin Shenyi
IPC: C12N5/071
Filed: 2019-08-05
Abstract: Provided is a method for culturing primary cells of a lung cancer solid tumor and primary tumor cells of a lung cancer pleural effusion, mainly comprising: (1) treating lung cancer solid tumor tissue with a mild cell dissociation reagent, and separating lung cancer cells in a pleural effusion using a gentle method, to maximize the vitality of the cancer cells; and (2) preparing a special serum-free medium, and using a suspension culture system to culture the tumor cells derived from the solid lung cancer tumor in vitro, so as to ensure normal expansion of the cancer cells while, maximally eliminating interference from normal cells. Further provided is a supporting reagent for the method. The lung cancer primary cell culture product obtained by the method can be used in various cell-level in vitro experiments, second-generation sequencing, construction of animal models, construction of cell lines, and other applications.
Patent AU-2019477233-A1 (AU)
Title: Systems and methods for automated application launching
Inventor: QIAO ZONGPENG
IPC: G06F9/44
Filed: 2019-12-02
Abstract: Methods and systems for automated application launching are described herein. A computing device may receive a message, the message indicative of an application for a given event and a time in which to launch the application for the given event, from a client device. Based on the content of the message, the computing device may generate a plurality of text strings based on content of the message. The computing device may identify the application based on a comparison of the plurality of text strings with one or more entries of a database of applications and may launch the application in response to the identification of the application and at the time indicated in the received message, so as to make ready the application for use for the given event.
Patent WO-2021062487-A1 (WO)
Inventor: BREADMORE MICHAEL C
IPC: B29C64/40
Filed: 2020-10-02
Abstract: A 3D printed porous membrane and a method of producing same. The method including depositing an array of droplets of a first curable material and droplets of a second curable material across a build plane, wherein the first material is insoluble in a solvent and the second material is soluble in the solvent; flattening the droplets of the first and second material so that a plurality of droplets of the first material are intermixed with a plurality of droplets of the second material; curing the first and second material to form a layer of rigid material; depositing, flattening and curing further arrays of droplets on top of the layer of rigid material to form a 3D structure; soaking the 3D structure in the solvent to at least partially dissolve the second material and producing a 3D printed porous membrane made of the first material.
Patent AU-2020203714-A1 (AU)
Title: Methods of separating gemcitabine-phosphate diastereoisomers
Inventor: GRIFFITH HUGH
IPC: C07H19/10
Filed: 2020-06-05
Abstract: This application relates to a method of separating the phosphate diastereoisomers of gemcitabine [phenyl-benzoxy-L-alaninyl)]-phosphate (NUC-1031) using crystallisation. In particular, crystallisation from isopropyl alcohol provides gemcitabine-[phenyl-benzoxy-L- alaninyl)]-(S)-phosphate in high diastereoisomerically pure form. This application also relates to a crystalline form of gemcitabine [phenyl-benzoxy-L-alaninyl)]-(S)-phosphate.
Patent AU-2020204098-A1 (AU)
Title: Bottom loaded pedicle screw
Inventor: DANIELS DAVID W
IPC: A61B17/70
Filed: 2020-06-19
Abstract: A pedicle screw includes a tulip head having an upper opening disposed in a top end of the tulip 
head and a lower opening disposed in a bottom end of the tulip head opposite the upper opening, 
wherein the upper and lower openings form a single cavity extending through the tulip head from 
5 a top end to the bottom end and the cavity having an interior wall, a retention groove disposed 
within the interior wall, and a stop disposed between the retention groove and upper opening and 
extending inwardly from the interior wall; a rod seat disposed within the cavity engaging the stop 
on a side closest to the lower opening, the rod seat having a rod mating face, a shank mating face 
opposite the rod mating face, and a hole disposed through the rod mating face and shank mating 
0 face; a screw shank having a thread disposed along a length of the screw shank and a connector 
positioned at an upper end of the screw shank; a retainer collar having a collar body, a pass 
through aperture disposed through the collar body, a locking ring groove disposed within an 
outer surface of the collar body, an anti-rotation tab extending from the collar body, and a collar 
expansion split disposed within the collar body, wherein the retainer collar disposed about the 
5 connector of the screw shank; and a locking ring disposed within the retention groove and the 
locking ring groove, wherein the locking groove has an unloaded outer diameter (Doi) which is 
greater than a diameter of the lower opening.  
CIN2000 2166087vl 
40504.00009
Patent AU-2020216914-A1 (AU)
Title: Amide-disubstituted pyridine or pyridazine compounds
Inventor: SHERWOOD TREVOR C
IPC: C07D413/12
Filed: 2020-01-28
Abstract: Compounds having the following formula (I): (Formula (I)) or a stereoisomer or pharmaceutically-acceptable salt thereof, are useful in the modulation of IL-12, IL-23 and/or IFNa, by acting on Tyk-2 to cause signal transduction inhibition.
Patent AU-2020219183-A1 (AU)
Title: Brain activity monitoring
Inventor: GUVENC UMUT
IPC: A61B5/291
Filed: 2020-02-05
Abstract: A system for monitoring brain activity of a subject, including an implantable measurement device including: a sensor configured to measure electrical activity in the brain; electronic measurement processing devices configured to: receive measurement data from the sensor; use the measurement data to determine if the brain activity of the subject is indicative of an event; and generate event data indicative of the brain activity associated with the event; and an implantable transceiver configured to transmit the event data; an inductive implantable coil configured to inductively receive power; and an external monitoring device including: an external transceiver configured to receive event data from the implantable measurement device; an inductive external coil configured to inductively transmit power to the implantable measurement device; and electronic monitoring processing devices configured to: generate subject data; and transfer the subject data to analysis processing devices for analysis.
Patent AU-2020223780-A1 (AU)
Title: Utility Meter
Inventor: JHALORA SURENDRA
IPC: G01R11/00
Filed: 2020-08-28
Abstract: A utility meter is provided and comprises: means for measuring the consumption of a utility; 
a housing for the measuring means; the housing associated with an optical detection means 
that is arranged to detect movement of part of the housing. In one embodiment, the optical 
detection means detects movement of the housing relative to the optical detection means.  
The optical detection means comprises a photo electric arrangement including an optical 
transmitter for emitting an optical signal and a receiver for receiving optical signals. the 
transmitter is operable to provide a variable bit light pattern including a predetermined 
signature that is recognisable by the receiver.  
19
Patent AU-2020227989-A1 (AU)
Title: Antibodies that bind to cleaved form of mutant calreticulin, and diagnostic, preventive, or therapeutic agent for myeloproliferative neoplasm
Inventor: ARAKI MARITO
IPC: G01N33/574
Filed: 2020-02-28
Abstract: Provided is a diagnostic, prophylactic or therapeutic drug for myeloproliferative neoplasms.　An antibody which can bind to a truncated mutant CALR protein and has an antigen-recognition site in (a) a polypeptide chain comprising the amino acid sequence represented by SEQ ID NO: 1 or (b) a polypeptide chain comprising such an amino acid sequence that one amino acid residue or several amino acid residues are deleted, substituted or added in SEQ ID NO: 1, or a functional fragment of the antibody; and a diagnostic, prophylactic or therapeutic drug for myeloproliferative neoplasms, which comprises the antibody.
Patent AU-2020230299-A1 (AU)
Title: Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
Inventor: BAUMEISTER JUDITH
IPC: C07K16/00
Filed: 2020-09-10
Abstract: This invention provides, and in certain specific but non-limiting aspects relates to: 
- assays that can be used to predict whether a given ISV will be subject to protein 
interference as described herein and/or give rise to an (aspecific) signal in such an assay 
(such as for example in an ADA immunoassay). Such predictive assays could for example 
be used to test whether a given ISV could have a tendency to give rise to such protein 
interference and/or such a signal; to select ISV's that are not or less prone to such protein 
interference or to giving such a signal; as an assay or test that can be used to test whether 
10 certain modification(s) to an ISV will (fully or partially) reduce its tendency to give rise 
to such interference or such a signal; and/or as an assay or test that can be used to guide 
modification or improvement of an ISV so as to reduce its tendency to give rise to such 
protein interference or signal; 
- methods for modifying and/or improving ISV's to as to remove or reduce their tendency 
to give rise to such protein interference or such a signal; 
- modifications that can be introduced into an ISV that remove or reduce its tendency to 
give rise to such protein interference or such a signal; 
- ISV's that have been specifically selected (for example, using the assay(s) described 
herein) to have no or low(er)/reduced tendency to give rise to such protein interference or 
20 such a signal; 
- modified and/or improved ISV's that have no or a low(er)/reduced tendency to give rise 
to such protein interference or such a signal.
Patent AU-2020250804-A1 (AU)
Title: Device and method for determining an elemental composition of ground
Inventor: SCHÜNGEL MICHAEL
IPC: G01N21/71
Filed: 2020-03-25
Abstract: The invention relates to a method for determining an elemental composition of ground (1) according to the depth (t), comprising: - taking a core sample (2) of the ground (1), and - determining the elemental composition of the ground (1) according to the depth (t) by analysing the core sample (2) taken by means of laser-induced breakdown spectroscopy, LIBS. With the described method and with the described device (3), it is possible to analyse ground (1), for example, a field used for agriculture or a building ground to be examined for pollutants. The quality of the ground (1) can be determined particularly efficiently and reliably comprehensively by analysis by means of PGNAA, PFTNA and/or LIBS.
Patent AU-2020269289-A1 (AU)
Title: Breathable film
Inventor: KOPLIN ROBERT
IPC: C08J5/18
Filed: 2020-05-02
Abstract: The invention relates to a breathable film. The specific ball-drop impact resistance of the film is more than 100 mm per gram polymer per square meter. The film has a water vapor permeability of at least 1000 g/m
Patent AU-2020273687-A1 (AU)
Title: Quinoline derivative used for soft tissue sarcoma combination therapy
Inventor: WANG ZHIMING
IPC: A61K31/704
Filed: 2020-05-11
Abstract: A quinoline derivative used for soft tissue sarcoma combination therapy, relating to a use of the quinoline derivative in combination with a second therapeutic drug to treat soft tissue sarcoma, wherein the second therapeutic drug may be a chemotherapy drug, a small molecule targeted anti-tumour drug or an immunotherapy drug. The chemical name of the quinoline derivative compound I is 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropylamine.
Patent AU-2020296087-A1 (AU)
Title: Patient selection for enhancement of anti-tumor immunity in cancer patients
Inventor: ROBERTS PATRICKS JOSEPH
IPC: A61K31/519
Filed: 2020-06-18
Abstract: A method for increasing the progression free survival or overall survival of a patient with cancer comprising: determining if the cancer has a surrounding microenvironment that is favorable to immune modulation; determining if the chemotherapy regimen induces immunogenic cell death, and if both are yes, administering an effective amount of a CDK 4/6 inhibitor selected from Compounds I, II, III, IV, or V, or a pharmaceutically acceptable salt thereof, wherein the CDK4/6 inhibitor is administered prior to the administration of the chemotherapy or optionally prior to and concurrently with chemotherapy; and, wherein the increase in progression free survival or overall survival is in comparison to the progression free survival or overall survival based on administration of the chemotherapy alone, either based on literature or otherwise publicly available evidence, a comparative during preclinical or clinical trials, or other means accepted by persons skilled in the field.
Patent AU-2020313634-A1 (AU)
Title: Insecticidal efficacy enhancer, insect pest control method, and water-based insecticidal composition to be vaporized and diffused by being heated
Inventor: MIYOSHI KAZUFUMI
IPC: A01N53/06
Filed: 2020-07-03
Abstract: Provided is an insecticidal efficacy enhancer that can effectively enhance the insecticidal efficacy of a pyrethroid insecticide component having a relatively high vapor pressure in an aqueous insecticide composition for thermal transpiration that contains the pyrethroid insecticide component. The insecticidal efficacy enhancer contains, as an active ingredient, a glycol-based compound in which a hydroxyl group is bonded to each of two adjacent carbon atoms in an alkane having 4-7 carbon atoms. The insecticidal efficacy enhancer is blended in an aqueous insecticide composition for thermal transpiration that contains a pyrethroid insecticide component having a vapor pressure of 2×10
Patent AU-2020319934-A1 (AU)
Title: A moulded pulp fibre product, and method of forming same
Inventor: APPLEFORD MARK
IPC: B32B1/02
Filed: 2020-07-30
Abstract: A method of forming a moulded pulp fibre product involves forming two or more pulp fibre pre-forms that each include at least one mating surface. Each pre-form is made from a suspension of pulp fibres in liquid. The pulp fibre pre-forms are assembled into a set in which adjacent pulp fibre pre-forms have mating surfaces that are in contact with, or adjacent to one another. The set of pulp fibre pre-forms are then bonded to form a pulp fibre laminate.
Patent AU-2020320022-A1 (AU)
Title: Serotonergic agent and 5-HT1A-receptor antagonist
Inventor: WALDINGER MARCEL DAVID
IPC: A61K31/4525
Filed: 2020-07-29
Abstract: The present invention relates to a 5-HT1A-receptor antagonist or a derivative, precursor or metabolite thereof, in combination with at least one serotonergic agent or a derivative, precursor or metabolite thereof for use in the prevention and/or treatment of premature ejaculation, wherein the 5-HT1A-receptor antagonist or a derivative, precursor or metabolite thereof is administered separately, sequentially or simultaneously to the at least one serotonergic agent or a derivative, precursor or metabolite thereof.
Patent AU-2020347043-A1 (AU)
Title: A new, non-specific thermolabile nuclease active at low temperature, in wide pH range and high concentration in salts
Inventor: OLSZEWSKI MARCIN
IPC: C12N1/08
Filed: 2020-09-14
Abstract: The subject matter of this invention is a new thermolabile PPR nuclease or its enzymatically active fragment exhibiting high catalyst activity in difficult reaction conditions (particularly high concentrations of salts and other additives commonly used in the processes of the purification of proteins and viruses, low temperatures and wide range of pH), where the nuclease sequence is SEQ.2 or a sequence that shares at least 40% of its identity. The subject matter of the invention is also the gene encoding PPR nuclease or its enzymatically active fragment; a particle of nucleic acid encoding the PPR nuclease or its enzymatically active fragment; expression plasmid including the sequence of the PPR encoding gene; recombinant strains of Escherichia coli JM109(DE3) pD454-PPR-AmpR and E. coli ArcticExpress (DE3) pD454-PPR-AmpR; the method of PPR nuclease protein production, application of PPR nuclease in processes of purification of recombinant proteins of significantly lower DNA content. As well as for decontamination of reactive reagents and mixtures for PCR, qPCR, RT- PCR, RT-qPCR, RCA, LAMP and NGS in order to obtain higher sensitivity and specificity of relevant genetic analyses; application of the PPR nuclease in processes of virus vector purification (particularly lentiviruses [LV], adenoviruses [AV, AAV] and retroviruses [RV] used in modem gene and cell therapies (chimeric antigen receptor [CAR] T-cell immunotherapy)); application of the PPR nuclease in exosome purification processes for therapeutic or diagnostic purposes; application of the PPR nuclease in processes of recombinant protein purification, particularly enzymes, antibodies, vaccination antigens, products used in cell therapies and other therapeutic proteins.